www.mhlw.go.jp/stf/newpage_19940.html
archives
This URL has 1 public saves. The first save was Apr 3, 2026, 06:30 PM and the latest save was Apr 3, 2026, 06:30 PM.
View recent saves on this domain
Latest saved version
新型コロナウイルス治療薬の特例承認について｜厚生労働省
This is the newest public snapshot for this URL and the best place to start reviewing the page.
Source URL
https://www.mhlw.go.jp/stf/newpage_19940.html
About this page
This page announces the special approval of a COVID-19 treatment drug by Japan's Ministry of Health, Labour and Welfare on July 19, 2021. Under Article 14-3 of the Pharmaceutical Affairs Law, Chugai Pharmaceutical Co., Ltd.'s drug "Ronapreve Intravenous Infusion Set" (generic names: casirivimab and imdevimab) received special approval for treating SARS-CoV-2 infection. The application was submitted on June 29, 2021.
Saved versions
www.mhlw.go.jp/stf/newpage_19940.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.